Literature DB >> 2551925

Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.

C S Liang1, T H Fan, J T Sullebarger, S Sakamoto.   

Abstract

The reduction of myocardial beta-adrenoceptor density in congestive heart failure has been thought to be caused by agonist-induced homologous desensitization. However, recent evidence suggests that excessive adrenergic stimulation may not produce myocardial beta-receptor downregulation unless there is an additional defect in the local norepinephrine (NE) uptake mechanism. To investigate the association between beta-adrenoceptor regulation and NE uptake activity, we carried out studies in 30 dogs with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary artery constriction and 23 sham-operated control dogs. We determined NE uptake activity by measuring accumulation of [3H]NE in tissue slices, NE uptake-1 carrier density by [3H]mazindol binding and beta-adrenoceptor density by [3H]dihydroalprenolol binding. Compared with sham-operated dogs, RHF dogs showed a 26% decrease in beta-adrenoceptor density, a 51% reduction in NE uptake activity, and a 57% decrease in NE uptake-1 carrier density in their right ventricles. In addition, right ventricle beta-receptor density correlated significantly with NE uptake activity and NE uptake-1 carrier density. In contrast, neither NE uptake activity nor beta-receptor density in the left ventricle and renal cortex was affected by RHF. Thus, the failing myocardium is associated with an organ- and chamber-specific subnormal neuronal NE uptake. This chamber-specific loss of NE uptake-1 carrier could effectively reduce local NE clearance, and represent a local factor that predisposes the failing ventricle to beta-adrenoceptor downregulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551925      PMCID: PMC329787          DOI: 10.1172/JCI114294

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  SYNTHESIS, BINDING, RELEASE, AND METABOLISM OF NOREPINEPHRINE IN NORMAL AND TRANSPLANTED DOG HEARTS.

Authors:  L T POTTER; T COOPER; V L WILLMAN; D E WOLFE
Journal:  Circ Res       Date:  1965-05       Impact factor: 17.367

2.  Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.

Authors:  T H Fan; C S Liang; S Kawashima; S P Banerjee
Journal:  Eur J Pharmacol       Date:  1987-08-11       Impact factor: 4.432

3.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

4.  Mechanism of myocardial catecholamine depletion in cardiac hypertrophy and failure in rabbits.

Authors:  H Sassa
Journal:  Jpn Circ J       Date:  1971-04

Review 5.  Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.

Authors:  R J Lefkowitz; M G Caron; G L Stiles
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

Review 6.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Authors:  T K Harden
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

7.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

8.  Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.

Authors:  S M Heilbrunn; P Shah; M R Bristow; H A Valantine; R Ginsburg; M B Fowler
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

9.  Norepinephrine increases beta-receptors and adenylate cyclase in canine myocardium.

Authors:  W J Raum; M M Laks; D Garner; M H Ikuhara; R S Swerdloff
Journal:  Am J Physiol       Date:  1984-01

10.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

View more
  26 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats.

Authors:  K Leineweber; T Seyfarth; O E Brodde
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Expressions of cardiac sympathetic norepinephrine transporter and beta1-adrenergic receptor decreased in aged rats.

Authors:  He Li; Xiao-qing Ma; Fan Ye; Jing Zhang; Xin Zhou; Zhi-hong Wang; Yu-ming Li; Guo-yuan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

4.  Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.

Authors:  Erica A Wehrwein; Lindsay M Parker; Anna A Wright; John M Spitsbergen; Martin Novotny; Dagmar Babankova; Greg M Swain; Beth A Habecker; David L Kreulen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

5.  Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves.

Authors:  Diana C Parrish; Eric N Alston; Hermann Rohrer; Paul Nkadi; William R Woodward; Günther Schütz; Beth A Habecker
Journal:  Exp Physiol       Date:  2009-10-30       Impact factor: 2.969

Review 6.  Monoamine oxidases as sources of oxidants in the heart.

Authors:  Nina Kaludercic; Jeanne Mialet-Perez; Nazareno Paolocci; Angelo Parini; Fabio Di Lisa
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

7.  123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.

Authors:  I Mitani; S Sumita; N Takahashi; H Ochiai; M Ishii
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

8.  Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts.

Authors:  Nina Kaludercic; Andrea Carpi; Takahiro Nagayama; Vidhya Sivakumaran; Guangshuo Zhu; Edwin W Lai; Djahida Bedja; Agnese De Mario; Kevin Chen; Kathleen L Gabrielson; Merry L Lindsey; Karel Pacak; Eiki Takimoto; Jean C Shih; David A Kass; Fabio Di Lisa; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2013-05-22       Impact factor: 8.401

9.  Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.

Authors:  Y A Lee; C S Liang; M A Lee; K Lindpaintner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Low-level vagus nerve stimulation upregulates small conductance calcium-activated potassium channels in the stellate ganglion.

Authors:  Mark J Shen; Hyung-Wook Park; A George Akingba; Po-Cheng Chang; Shien-Fong Lin; Changyu Shen; Lan S Chen; Zhenhui Chen; Michael C Fishbein; Nipavan Chiamvimonvat; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2013-01-26       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.